MapLight Therapeutics, Inc.
corporate_fare Company Profile
MapLight Therapeutics, Inc. (NASDAQ:MPLT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for MPLT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- MapLight Therapeutics Reports Widened Q1 Net Loss and Doubled Operating Cash Burn, Confirms Runway Through 2027
- MapLight Therapeutics Completes Enrollment for Two Phase 2 Trials, Reports Q1 Results
- MapLight Therapeutics Reports 2025 Annual Results, Extends Cash Runway to 2027, and Details Pipeline Progress
- MapLight Therapeutics Reports Strong Cash Position & Key Clinical Milestones, Including Two Phase 2 Readouts in Q3 2026
- MapLight Therapeutics Nears Key Phase 2 Readouts in Q3 2026, Extends Cash Runway Through 2027
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$161.15M
Diluted EPS
-$18.56
Op. Cash Flow
-$138.14M
Free Cash Flow
-$138.61M
Operating Income
-$169.08M
Cash & Equivalents
$46.73M
Debt / Equity
0.00×
Shares Outstanding
44.02M sh
Source: 10-K · filed 2026-03-26 · accession 0001193125-26-125072
show_chartPrice Chart
Loading chart...
feed MPLT - Filings & News (Page 2)
MPLT
May 14, 2026, 4:25 PM EDT
Price at Filing:
$29.29
Real-time Price:
$5.94
Change:
-$23.35 (-80%)
Market Cap:
$330.12M
MPLT
May 14, 2026, 4:15 PM EDT
Price at Filing:
$29.29
Real-time Price:
$5.94
Change:
-$23.35 (-80%)
Market Cap:
$330.12M
MPLT
Mar 26, 2026, 7:20 AM EDT
Price at Filing:
$17.50
Real-time Price:
$5.94
Change:
-$11.56 (-66%)
Market Cap:
$330.12M
MPLT
Mar 26, 2026, 7:10 AM EDT
Price at Filing:
$18.14
Real-time Price:
$5.94
Change:
-$12.20 (-67%)
Market Cap:
$330.12M
MPLT
Mar 26, 2026, 7:00 AM EDT
Price at Filing:
$18.14
Real-time Price:
$5.94
Change:
-$12.20 (-67%)
Market Cap:
$330.12M
MPLT
Jan 09, 2026, 7:06 AM EST
Price at Filing:
$17.19
Real-time Price:
$5.94
Change:
-$11.25 (-65%)
Market Cap:
$330.12M